Trial
NCT00445705
Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Allergan
Collaborators
—
Condition
Fibromyalgia
Intervention
placebo
Why stopped
This study was terminated early due to company decision. Part B was never conducted.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-07